FIELD: medicine. SUBSTANCE: method involves determining relations between concentrations S(K1, Ko) or S(Kз, Ko) or S(K2, K1) or S(Kз, K1) or S(Kз, K2) of at least one cytokine in living organism or its cells, where Ko is the concentration before treatment, K1 is the concentration after treatment with substance, field or combinations of fields and/or substances under study, K2 is the concentration after treating with other biologically active substance, field or combinations of fields and/or substances, Kз is the concentration after treating with other biologically active substance, field or combinations of fields and/or substances and biologically active substance, field or combinations of fields and/or substances under study. EFFECT: enhanced effectiveness in determining living organism sensitivity. 7 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING LIVING ORGANISM SENSITIVITY TO CYTOKINE | 2000 |
|
RU2181889C1 |
METHOD FOR TREATMENT OF UROGENITAL INFECTIONS THAT ARE SEXUALLY TRANSMITTED AND CAUSED BY CHLAMYDIAE AND/OR MICOPLASMA | 2010 |
|
RU2441584C1 |
SUPPOSITORIES AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASES TRANSMITTED BY GENITAL TRACTS | 1999 |
|
RU2147873C1 |
CARBOXYMETHYLCELLULOSE COPOLYMER AND GOSSYPOL SODIUM SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR PROPHYLAXIS OR TREATMENT OF VIRAL DISEASE | 2004 |
|
RU2270708C1 |
HUMAN CONJUNCTIVA CELLULAR CULTURE CHANG ATCC-CCL 20.2 FOR PREVENTION OF THE PHENOMENON OF TOXICITY OF EYE INSTILLATION IN CASE OF THE JOINT APPLICATION OF MEDICINAL DRUGS | 2017 |
|
RU2646100C1 |
METHOD FOR PROPHYLAXIS AND CORRECTION OF IMMUNODEFICIENCY CONDITIONS | 2006 |
|
RU2318533C1 |
PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
Authors
Dates
2003-04-20—Published
2001-04-09—Filed